ACADIA PHARMACEUTICALS INC Quarterly Return On Equity in % from Q1 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Acadia Pharmaceuticals Inc quarterly/annual Return On Equity history and growth rate from Q1 2012 to Q3 2024.
  • Acadia Pharmaceuticals Inc Return On Equity for the quarter ending September 30, 2024 was 25.8 %.
  • Acadia Pharmaceuticals Inc annual Return On Equity for 2023 was -15.7 %, a 69% increase from 2022.
  • Acadia Pharmaceuticals Inc annual Return On Equity for 2022 was -50.7 %, a 70% decline from 2021.
  • Acadia Pharmaceuticals Inc annual Return On Equity for 2021 was -29.8 %, a 31.7% increase from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 25.8 +64.7 Jul 1, 2024 Sep 30, 2024
Q2 2024 6.89 +34.7 Apr 1, 2024 Jun 30, 2024
Q1 2024 -0.41 +35.3 +98.9% Jan 1, 2024 Mar 31, 2024
Q4 2023 -15.7 +35 +69% Oct 1, 2023 Dec 31, 2023
Q3 2023 -38.8 +8.25 +17.5% Jul 1, 2023 Sep 30, 2023
Q2 2023 -27.8 +13.4 +32.6% Apr 1, 2023 Jun 30, 2023
Q1 2023 -35.7 +4.82 +11.9% Jan 1, 2023 Mar 31, 2023
Q4 2022 -50.7 -20.9 -70% Oct 1, 2022 Dec 31, 2022
Q3 2022 -47.1 -14.4 -43.8% Jul 1, 2022 Sep 30, 2022
Q2 2022 -41.2 +1.93 +4.48% Apr 1, 2022 Jun 30, 2022
Q1 2022 -40.5 +0.65 +1.58% Jan 1, 2022 Mar 31, 2022
Q4 2021 -29.8 +13.8 +31.7% Oct 1, 2021 Dec 31, 2021
Q3 2021 -32.7 +7.61 +18.9% Jul 1, 2021 Sep 30, 2021
Q2 2021 -43.1 -9.63 -28.8% Apr 1, 2021 Jun 30, 2021
Q1 2021 -41.2 -1.76 -4.47% Jan 1, 2021 Mar 31, 2021
Q4 2020 -43.6 -0.74 -1.73% Oct 1, 2020 Dec 30, 2020
Q3 2020 -40.4 +9.8 +19.5% Jul 1, 2020 Sep 30, 2020
Q2 2020 -33.5 +37.5 +52.8% Apr 1, 2020 Jun 30, 2020
Q1 2020 -39.4 +40.3 +50.6% Jan 1, 2020 Mar 31, 2020
Q4 2019 -42.9 +34.3 +44.4% Oct 1, 2019 Dec 31, 2019
Q3 2019 -50.2 +38 +43.1% Jul 1, 2019 Sep 30, 2019
Q2 2019 -71 +7.59 +9.66% Apr 1, 2019 Jun 30, 2019
Q1 2019 -79.7 -8.26 -11.6% Jan 1, 2019 Mar 31, 2019
Q4 2018 -77.1 -4.12 -5.64% Oct 1, 2018 Dec 31, 2018
Q3 2018 -88.2 -20.5 -30.3% Jul 1, 2018 Sep 30, 2018
Q2 2018 -78.6 -16.5 -26.5% Apr 1, 2018 Jun 30, 2018
Q1 2018 -71.5 -8.4 -13.3% Jan 1, 2018 Mar 31, 2018
Q4 2017 -73 -17.4 -31.2% Oct 1, 2017 Dec 31, 2017
Q3 2017 -67.7 -9.23 -15.8% Jul 1, 2017 Sep 30, 2017
Q2 2017 -62.1 +2.17 +3.38% Apr 1, 2017 Jun 30, 2017
Q1 2017 -63.1 -1.44 -2.34% Jan 1, 2017 Mar 31, 2017
Q4 2016 -55.7 +12.3 +18.1% Oct 1, 2016 Dec 31, 2016
Q3 2016 -58.5 -3.89 -7.13% Jul 1, 2016 Sep 30, 2016
Q2 2016 -64.3 -19.2 -42.7% Apr 1, 2016 Jun 30, 2016
Q1 2016 -61.6 -25.6 -70.8% Jan 1, 2016 Mar 31, 2016
Q4 2015 -68 -40.7 -149% Oct 1, 2015 Dec 31, 2015
Q3 2015 -54.6 -29.8 -120% Jul 1, 2015 Sep 30, 2015
Q2 2015 -45 -22 -95.6% Apr 1, 2015 Jun 30, 2015
Q1 2015 -36.1 -14.3 -65.3% Jan 1, 2015 Mar 31, 2015
Q4 2014 -27.3 -2.96 -12.2% Oct 1, 2014 Dec 31, 2014
Q3 2014 -24.8 +0.03 +0.12% Jul 1, 2014 Sep 30, 2014
Q2 2014 -23 +3.83 +14.3% Apr 1, 2014 Jun 30, 2014
Q1 2014 -21.8 +20.7 +48.7% Jan 1, 2014 Mar 31, 2014
Q4 2013 -24.3 +38.4 +61.2% Oct 1, 2013 Dec 31, 2013
Q3 2013 -24.8 +83.6 +77.1% Jul 1, 2013 Sep 30, 2013
Q2 2013 -26.9 +80.8 +75.1% Apr 1, 2013 Jun 30, 2013
Q1 2013 -42.6 +48.3 +53.1% Jan 1, 2013 Mar 31, 2013
Q4 2012 -62.7 Oct 1, 2012 Dec 31, 2012
Q3 2012 -108 Jul 1, 2012 Sep 30, 2012
Q2 2012 -108 Apr 1, 2012 Jun 30, 2012
Q1 2012 -90.9 Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.